New therapeutic options for urge incontinence.
A critical evaluation of the literature published over the past year reveals several therapeutic options for urge incontinence. Basic science advances in understanding the pathophysiology of bladder instability are paramount in the development of new therapeutic options, chief of which is sacral neuromodulation. Epidemiologic studies from around the world impact the therapies and diagnosis. Therapies include hormone delivery systems, pharmaceutical, combined behavioral and drug, botulinum, surgery, magnetic stimulation, and sacral neuromodulation.
Indiana University, 1633 N. Capital Avenue, Indianapolis, IN 46202, USA. jtbens8000@aol.com
J T
JT
Benson
D000368:Aged; D001521:Behavior Therapy; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D003131:Combined Modality Therapy; D004599:Electric Stimulation Therapy / Q000379:methods; D005260:Female; D006801:Humans; D008875:Middle Aged; D017060:Patient Satisfaction; D011788:Quality of Life; D004561:Transcutaneous Electric Nerve Stimulation; D016896:Treatment Outcome; D014550:Urinary Incontinence, Stress / Q000175:diagnosis / Q000628:therapy*; D014567:Urography; D013520:Urologic Surgical Procedures / Q000379:methods
D018680:Cholinergic Antagonists